Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DGICB vs HRTG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HRTG Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

HRTG Overall Winner 6-Pillar Tally: DGICB 0 – 5 HRTG (1 Tie) Matrix Metrics: DGICB 2 – 8 HRTG

As of Nov 16, 2026, Heritage Insurance Holdings Inc (HRTG) is the stronger overall head-to-head candidate over DGICB (DGICB) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HRTG carries 61.1/100 (BUY) at $33.83 (6.6x Forward P/E, 34.1% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DGICB vs HRTG
DGICB US Equity
DGICB
Institutional Equity
$28.55
+1.21% 1D
Market Cap $1.1B
TTM Revenue $955M
Forward P/E 14.4x
Beta / 30D Vol 0.27β · 86% Vol
Unified Composite Score
30.8 / 100 SELL
Tech 5.0 Fund 27.0 Flow 50.0 Mom 31.5
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 67
RSI-14: 66.6 · SMA20: $25.16 · SMA50: $21.89
HRTG NYSE Head-to-Head Winner
Heritage Insurance Holdings Inc
Fire, Marine & Casualty Insurance
$33.83
+0.45% 1D
Market Cap $998.0M
TTM Revenue $861M
Forward P/E 6.6x
Beta / 30D Vol -0.12β · 35% Vol
Unified Composite Score
61.1 / 100 BUY
Tech 59.0 Fund 53.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 43
RSI-14: 43.3 · SMA20: $35.19 · SMA50: $34.80

6-Pillar Scorecard Institutional Category Breakdown (DGICB 0 – 5 HRTG)

Columns: Metric · DGICB · HRTG
1. Valuation Multiples HRTG
Forward P/E 14.4x 6.6x
Trailing P/E 15.2x 4.8x
PEG Ratio 1.90x N/M
EV / Revenue 1.1x 1.2x
2. Growth & Scale HRTG
Revenue Growth (YoY) -3.4% +3.2%
Earnings Growth (YoY) -11.3% +5.6%
TTM Revenue (USD) $955M $861M
Market Cap $1.1B $998.0M
3. Profitability & Quality HRTG
Gross Margin 9.2% 45.1%
Operating Margin 9.0% 34.1%
Net Profit Margin 7.2% 25.1%
Return on Equity (ROE) 10.7% 41.7%
4. Balance Sheet & Cash Flow HRTG
Cash Generation (TTM) $88M EBITDA $306M EBITDA
Cash Flow Margin 9.2% EBITDA Mgn 35.5% EBITDA Mgn
Net Cash / Leverage $17.70 Book/Sh · 10.7% ROE $20.83 Book/Sh · 41.7% ROE
Dividend Yield 2.69% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 54.9% (67th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HRTG
OpEx & R&D Intensity N/A 11.0% of Rev ($95M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Insurance - Property & Casualty Operator Insurance - Property & Casualty Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DGICB (2) vs HRTG (8)
Institutional Metric DGICB HRTG Criterion Row Edge
Market Capitalization
Scale
$1.1B $998.0M Larger Scale DGICB
Trailing P/E Ratio
Valuation
15.2x 4.8x Lower Multiple HRTG
Forward P/E Ratio
Valuation
14.4x 6.6x Lower Multiple HRTG
Revenue Growth (YoY)
Growth
-3.4% +3.2% Higher Growth HRTG
Operating Margin (TTM)
Profitability
9.0% 34.1% Higher Margin HRTG
Net Profit Margin
Profitability
7.2% 25.1% Higher Margin HRTG
Return on Equity (ROE)
Capital Efficiency
10.7% 41.7% Higher ROE HRTG
52-Week Range Position
Momentum
91% ($14–$30) 77% ($20–$38) Stronger Trend DGICB
Beta / 30D Volatility
Risk Regime
0.27β · 86% Vol -0.12β · 35% Vol Lower Realized Risk HRTG
Unified Institutional Score
Composite Signal
30.8 / 100 (SELL) 61.1 / 100 (BUY) Higher Composite HRTG
Trailing 12M Revenue (USD)
Operating Scale
$955M $861M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
9.2% 45.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.90x PEG · 1.1x EV/Rev N/M PEG · 1.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$88M EBITDA ($17.70 Book/Sh · 10.7% ROE) $306M EBITDA ($20.83 Book/Sh · 41.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DGICB +56.68 pp
DGICB: +49.09% · HRTG: -7.59%
3M Horizon DGICB +17.0 pp
DGICB: +30.37% · HRTG: +13.37%
6M Horizon DGICB +35.43 pp
DGICB: +63.14% · HRTG: +27.71%
1Y Horizon DGICB +68.02 pp
DGICB: +77.72% · HRTG: +9.7%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DGICB vs HRTG. Trailing 12-month operating profitability (DGICB 9.0% vs HRTG 34.1%) and valuation multiples (DGICB 14.4x vs HRTG 6.6x Forward P/E) are benchmarked directly in Pillar 4 below.

DGICB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$955M
Gross Margin9.2%
Op. Margin9.0%
ROE / Fwd P/E10.7% · 14.4x
HRTG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$861M
Gross Margin45.1%
Op. Margin34.1%
ROE / Fwd P/E41.7% · 6.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DGICB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DGICB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HRTG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 54.9%
IV Percentile 67th %ile
Put/Call OI Skew N/A
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HRTG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DGICB Moat Profile Cyclical / Execution-Driven Positioning
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $1.1B market capitalization and 9.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HRTG Moat Profile High-Margin Pricing Power Moat
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $998.0M market capitalization and 34.1% operating margin.
OpEx & R&D Reinvestment 11.0% of Rev ($95M)
90D Engineering Disclosures 0 Published

Investor FAQ DGICB vs HRTG Key Questions & Quantitative Answers

As of Nov 16, 2026, Heritage Insurance Holdings Inc (HRTG) is the stronger overall head-to-head candidate over DGICB (DGICB) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HRTG carries 61.1/100 (BUY) at $33.83 (6.6x Forward P/E, 34.1% operating margin). Technically, DGICB sits in a Markup phase (RSI 66.6, UNCLASSIFIED options structure) and HRTG sits in a Neutral phase (RSI 43.3, UNCLASSIFIED options structure).

HRTG leads the Growth & Scale pillar: DGICB posts -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin), compared with HRTG at +3.2% YoY revenue growth and +5.6% YoY earnings growth on $861M TTM revenue (45.1% gross margin, 34.1% operating margin). On trailing 12-month operating scale, DGICB generates $955M in USD-normalized revenue versus $861M for HRTG. In operating R&D and SG&A reinvestment, DGICB deploys N/A (0 90-day corporate R&D disclosures) versus 11.0% of Rev ($95M) (0 disclosures) for HRTG.

HRTG screens cheaper on headline valuation multiples. DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin), whereas HRTG trades at 6.6x Forward P/E, 4.8x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (35.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGICB (10.7% ROE) versus HRTG (41.7% ROE) capital efficiency.

In options market volatility and institutional positioning, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk). By comparison, HRTG carries 54.9% implied volatility (67th %ile, Elevated (60th–80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.12β · 35% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.